Due to ongoing concerns about the spread of COVID-19 some early 2021 meetings have been rescheduled. Learn More

Immunotherapies and Mechanisms of Immune Escape

October 28–31, 2021

Original Dates: Februray 11–14, 2021

Chaired By

 Esra Akbay, PhD, UT Southwestern Medical Center
 Monica Guzman, PhD, Weill Cornell Medicine

Important Dates

 08/11/2021 -  Travel Form Due
 09/11/2021 -  Abstracts Due

Venue Information

Hilton Denver Inverness
200 Inverness Drive West
Englewood, CO 80112


Travel Agent Information

 Meeting #: Refer to your packet.
 Hours: 8:00am – 8:00 pm EST M-F
 Domestic: 669-210-8002
 International : 623-516-6140

About the Forbeck Foundation

 Forbeck Forum Information
 Travel Information
 General Program
 Frequently Asked Questions
 How to donate to WGFRF

Program Description

Modern immunotherapy concepts have changed cancer treatment paradigms, such as immune checkpoint blockade, chimeric antigen receptor (CAR) T cells, and antibody-based therapies have made rapid progress in the past 10 years and are currently used to treat many cancers. Immune checkpoint inhibition circumvents tumor-induced suppression of cytotoxic T cell function. Adoptive transfer of T cells expressing chimeric antigen receptors (CARs) are currently approved treat CD19-positive cancers. However, only a fraction of patients responds, especially in the field of solid tumors as, for example, the immune microenvironment plays a critical role in disease progression and outcomes as it can induce immune suppressive signals that prevent immune-surveillance and allow malignant cells to persist. Therefore, combination treatments using different kind of immunotherapies targeting multiple checkpoints are necessary for more effective responses. Discussing all the components that are known to play a role in the mechanisms of immune escape and the emerging concepts for therapeutic interventions in a multidisciplinary setting will lead to the implementation of rationally designed trials to better harness immune system for the benefit of cancer patients.

Forum Participants

Participant Institution
Andrea Cossarizza, MD, PhD University of Modena and Reggio Emilia
Lorenzo Galluzzi, PhD Weill Cornell Medical College
Juliet Gray, MA, MB BS, FRCPCH, PhD University of South Hampton
Annette Künkele, MD Charite - University Hospital Berlin
Fabiana Perna, MD PhD Indiana University
David Raulet, PhD University of California Berkeley
Antoni Ribas, MD, PhD University of California Los Angeles
Ankur Singh, PhD Georgia Institute of Technology
Marcel Van Den Brink, MD, PhD Memorial Sloan Kettering Cancer Center
Loems Ziegler-Heitbrock, MD Helmholtz Zentrum München

Forum Scholars

Scholar Institution

Airport Information

Denver International Airport (DIA) is approximately 1 hour from the meeting location.

  • Arrivals - Thursday at 1 PM, 3 PM and 5 PM
  • Departures - Sunday at 10 AM and 12 PM

International participants are welcome to arrive on Wednesday to minimize chances for missed or delayed connections.

Submit Travel Form


The abstracts should be only one or two paragraphs outlining the theme of your presentation and should reflect the objective and spirit of the meeting (see above). Abstracts will be circulated about one week before the meeting. The meeting organizer will start requesting them a month before the meeting.

Submit Abstract

For more than 30 years, the Forbeck Foundation has proven to be an excellent steward of donor funds and has remained focused on executing its mission. Interested in sponsoring this Forum? Contact us today for more information!